Navigation Links
Glaucoma May Boost Cardiovascular Death Risk in Blacks
Date:3/11/2008

Inappropriate treatment with beta blockers, other meds also increases odds, study finds

TUESDAY, March 11 (HealthDay News) -- Black people diagnosed and treated for glaucoma and those with high pressure in their eyes may be at increased risk for cardiovascular death, a new study suggests.

"Glaucoma is one of the leading causes of visual impairment worldwide," the researchers from Stony Brook University in Stony Brook, N.Y., wrote as background information in the study. "The most common type, primary open-angle glaucoma, is especially prevalent in populations of African origin, in which it is the foremost cause of blindness."

In addition to higher rates of open-angle glaucoma, blacks also tend to have higher rates of high pressure in their eyes (ocular hypertension) and higher rates of death from chronic disease than whites, the study authors noted.

They analyzed data on 4,092 people, aged 40 to 84 (average age 58.6), who took part in the Barbados Eye Studies of a predominately black population with similar ancestry to black Americans.

During the initial study visits that took place between 1987 and 1992, participants' height, weight and blood pressure were recorded, they were interviewed, and various eye measurements -- including photos of the retina and eye pressure assessments -- were taken.

At the start of the study, 300 participants had glaucoma, including 141 who'd been diagnosed and treated. After nine years of follow-up, 764 (19 percent) of the participants had died.

After the researchers adjusted for other factors, they concluded that glaucoma was not associated with risk of death overall. However, they did find that the risk of cardiovascular death was: 28 percent higher in those with ocular hypertension at the start of the study; 38 percent higher in people who'd previously been diagnosed with or treated for open angle glaucoma; and 91 percent higher in those who'd been treated with a beta blocker drug called timolol maleate.

The findings were published in the March issue of the Archives of Ophthalmology.

"One explanation for the excess mortality [death] found in persons with previously diagnosed open-angle glaucoma could be their longer duration of disease compared with those with newly diagnosed disease," the study authors wrote. "Another explanation for an increased mortality risk could be related to the open-angle glaucoma treatment received."

They noted that inappropriate use, or adverse effects, of beta blockers and other medications used to treat glaucoma may damage the cardiovascular system. They also said there's some evidence that risk factors for ocular hypertension and cardiovascular disease are similar.

"These findings underscore the importance of close monitoring and controlling of adequate intraocular pressure levels in this and other high-risk populations," the researchers concluded.

More information

The U.S. National Eye Institute has more about glaucoma.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, March 10, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mayor Bloomberg Declares March 6, 2008 World Glaucoma Day in New York City
2. Dr. Welsh Self-Test Diagnoses Glaucoma, the Leading Cause of Preventable- Blindness
3. Upcoming meeting will explore new technologies for glaucoma clinical drug trials
4. January is National Glaucoma Awareness Month
5. Cost of glaucoma medications may impact treatment
6. Looking at Glaucoma as a Systemic Disease
7. Chair of U.S. Preventive Services Task Force Pledges to Recommend Re-evaluation of Recent Glaucoma Findings
8. Glaucoma surgery in the blink of an eye
9. Glaucoma surgery in the blink of an eye
10. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
11. New Method Boosts Cardiac Arrest Survival
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Glaucoma May Boost Cardiovascular Death Risk in Blacks
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, a trusted name in ... trial program for all of the company’s desktop riser products. A simple application ... experience. , FlexiSpot’s unique desktop risers use an advanced dual gas spring hovering ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, ... ... today, featuring an inspirational interview of two ostomy patients, standing as living proof ... million people suffer from digestive diseases and issues that spike around the holidays. ...
(Date:12/2/2016)... Hawaii (PRWEB) , ... December 02, 2016 , ... ... 2016 at the Hyatt Regency Waikiki Beach Resort and Spa in Honolulu, offering ... in the field of pain management. , The demand for supplemental training ...
(Date:12/2/2016)... , ... December 02, 2016 , ... "Pro3rd Accents Volume ... editors to create versatile lower third titles with just a few clicks of the ... Volume 2 includes 30 lower third animations. Choose from various styles with accented animations, ...
(Date:12/2/2016)... ... December 02, 2016 , ... ‘Tis the season for giving! Today, 20 creative ... National Family Partnership and the Drug Enforcement Administration as part of the National Red ... 10 winning schools who decorated their campuses with this year’s Red Ribbon Week theme: ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Spain , Dec. 2, 2016 In ... natural sources apart from those derived from C. sativa, ... the Universita` di Napoli Federico II , the ... created the first comprehensive, critical, integrated and unified inventory ... The article focuses on the remarkable chemical and ...
(Date:12/2/2016)... Dec. 2, 2016  The Addiction Treatment Advisory ... of Managed Care Pharmacy (AMCP), has released detailed ... address the opioid addiction crisis, including through improved ... ATAG,s newly released paper, "The Role ... Naloxone," addresses many issues around gaps and barriers ...
(Date:12/2/2016)... , Dec. 2, 2016  Maxor National Pharmacy Services, LLC ... Pharmaceutical Specialties, Inc. ("PSI").  The combination of Texas ... Georgia -based PSI bring together both company,s clinical expertise ... and payers an industry-leading specialty pharmacy. About Maxor ... , , ...
Breaking Medicine Technology: